MLICM
CABA icon

Metropolitan Life Insurance Company (MetLife)’s Cabaletta Bio CABA Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,021
Closed -$34.5K – 351
2024
Q1 		$34.5K Hold
2,021
– – ﹤0.01% 1586
2023
Q4 		$45.9K Hold
2,021
– – ﹤0.01% 1494
2023
Q3 		$30.8K Buy
2,021
+615
+44% +$8.4K ﹤0.01% 1667
2023
Q2 		$18.2K Buy
+1,406
New +$15.3K ﹤0.01% 1986

Other funds holding CABA

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s CABA Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Cabaletta Bio (CABA) in Q2 2024, closing a stake of 2,021 shares — an estimated $34.5K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in CABA in Q2 2023 and held it in 4 quarters. The position peaked at $45.9K in Q4 2023. 142 funds tracked by Wall St. Rank hold CABA as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Cabaletta Bio position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,021 Cabaletta Bio shares in Q2 2024, an estimated $34.5K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Cabaletta Bio in Q2 2023 and held it in 4 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Cabaletta Bio position peaked at $45.9K in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Cabaletta Bio as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.